Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer & Tumor Profiling and Pathways Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Immunoassays
1.2.3 Next Generation Sequencing (NGS)
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 In-Situ Hybridization (ISH)
1.2.6 Microarrays
1.2.7 Mass Spectrometry
1.2.8 Others
1.3 Market by Application
1.3.1 Global Cancer & Tumor Profiling and Pathways Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Research
1.3.3 Clinical
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer & Tumor Profiling and Pathways Market Perspective (2018-2033)
2.2 Cancer & Tumor Profiling and Pathways Growth Trends by Region
2.2.1 Global Cancer & Tumor Profiling and Pathways Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cancer & Tumor Profiling and Pathways Historic Market Size by Region (2018-2023)
2.2.3 Cancer & Tumor Profiling and Pathways Forecasted Market Size by Region (2024-2033)
2.3 Cancer & Tumor Profiling and Pathways Market Dynamics
2.3.1 Cancer & Tumor Profiling and Pathways Industry Trends
2.3.2 Cancer & Tumor Profiling and Pathways Market Drivers
2.3.3 Cancer & Tumor Profiling and Pathways Market Challenges
2.3.4 Cancer & Tumor Profiling and Pathways Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer & Tumor Profiling and Pathways Players by Revenue
3.1.1 Global Top Cancer & Tumor Profiling and Pathways Players by Revenue (2018-2023)
3.1.2 Global Cancer & Tumor Profiling and Pathways Revenue Market Share by Players (2018-2023)
3.2 Global Cancer & Tumor Profiling and Pathways Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer & Tumor Profiling and Pathways Revenue
3.4 Global Cancer & Tumor Profiling and Pathways Market Concentration Ratio
3.4.1 Global Cancer & Tumor Profiling and Pathways Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer & Tumor Profiling and Pathways Revenue in 2022
3.5 Cancer & Tumor Profiling and Pathways Key Players Head office and Area Served
3.6 Key Players Cancer & Tumor Profiling and Pathways Product Solution and Service
3.7 Date of Enter into Cancer & Tumor Profiling and Pathways Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer & Tumor Profiling and Pathways Breakdown Data by Type
4.1 Global Cancer & Tumor Profiling and Pathways Historic Market Size by Type (2018-2023)
4.2 Global Cancer & Tumor Profiling and Pathways Forecasted Market Size by Type (2024-2033)
5 Cancer & Tumor Profiling and Pathways Breakdown Data by Application
5.1 Global Cancer & Tumor Profiling and Pathways Historic Market Size by Application (2018-2023)
5.2 Global Cancer & Tumor Profiling and Pathways Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cancer & Tumor Profiling and Pathways Market Size (2018-2033)
6.2 North America Cancer & Tumor Profiling and Pathways Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cancer & Tumor Profiling and Pathways Market Size by Country (2018-2023)
6.4 North America Cancer & Tumor Profiling and Pathways Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer & Tumor Profiling and Pathways Market Size (2018-2033)
7.2 Europe Cancer & Tumor Profiling and Pathways Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cancer & Tumor Profiling and Pathways Market Size by Country (2018-2023)
7.4 Europe Cancer & Tumor Profiling and Pathways Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer & Tumor Profiling and Pathways Market Size (2018-2033)
8.2 Asia-Pacific Cancer & Tumor Profiling and Pathways Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cancer & Tumor Profiling and Pathways Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer & Tumor Profiling and Pathways Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer & Tumor Profiling and Pathways Market Size (2018-2033)
9.2 Latin America Cancer & Tumor Profiling and Pathways Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cancer & Tumor Profiling and Pathways Market Size by Country (2018-2023)
9.4 Latin America Cancer & Tumor Profiling and Pathways Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer & Tumor Profiling and Pathways Market Size (2018-2033)
10.2 Middle East & Africa Cancer & Tumor Profiling and Pathways Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cancer & Tumor Profiling and Pathways Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer & Tumor Profiling and Pathways Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina, Inc. (US)
11.1.1 Illumina, Inc. (US) Company Detail
11.1.2 Illumina, Inc. (US) Business Overview
11.1.3 Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Introduction
11.1.4 Illumina, Inc. (US) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023)
11.1.5 Illumina, Inc. (US) Recent Development
11.2 QIAGEN N.V. (Germany)
11.2.1 QIAGEN N.V. (Germany) Company Detail
11.2.2 QIAGEN N.V. (Germany) Business Overview
11.2.3 QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Introduction
11.2.4 QIAGEN N.V. (Germany) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023)
11.2.5 QIAGEN N.V. (Germany) Recent Development
11.3 NeoGenomics Laboratories, Inc. (US)
11.3.1 NeoGenomics Laboratories, Inc. (US) Company Detail
11.3.2 NeoGenomics Laboratories, Inc. (US) Business Overview
11.3.3 NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Introduction
11.3.4 NeoGenomics Laboratories, Inc. (US) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023)
11.3.5 NeoGenomics Laboratories, Inc. (US) Recent Development
11.4 HTG Molecular Diagnostics, Inc. (US)
11.4.1 HTG Molecular Diagnostics, Inc. (US) Company Detail
11.4.2 HTG Molecular Diagnostics, Inc. (US) Business Overview
11.4.3 HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Introduction
11.4.4 HTG Molecular Diagnostics, Inc. (US) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023)
11.4.5 HTG Molecular Diagnostics, Inc. (US) Recent Development
11.5 Sysmex Corporation (Japan)
11.5.1 Sysmex Corporation (Japan) Company Detail
11.5.2 Sysmex Corporation (Japan) Business Overview
11.5.3 Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Introduction
11.5.4 Sysmex Corporation (Japan) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023)
11.5.5 Sysmex Corporation (Japan) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer & Tumor Profiling and Pathways Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Immunoassays
Table 3. Key Players of Next Generation Sequencing (NGS)
Table 4. Key Players of Polymerase Chain Reaction (PCR)
Table 5. Key Players of In-Situ Hybridization (ISH)
Table 6. Key Players of Microarrays
Table 7. Key Players of Mass Spectrometry
Table 8. Key Players of Others
Table 9. Global Cancer & Tumor Profiling and Pathways Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Cancer & Tumor Profiling and Pathways Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Cancer & Tumor Profiling and Pathways Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Cancer & Tumor Profiling and Pathways Market Share by Region (2018-2023)
Table 13. Global Cancer & Tumor Profiling and Pathways Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Cancer & Tumor Profiling and Pathways Market Share by Region (2024-2033)
Table 15. Cancer & Tumor Profiling and Pathways Market Trends
Table 16. Cancer & Tumor Profiling and Pathways Market Drivers
Table 17. Cancer & Tumor Profiling and Pathways Market Challenges
Table 18. Cancer & Tumor Profiling and Pathways Market Restraints
Table 19. Global Cancer & Tumor Profiling and Pathways Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Cancer & Tumor Profiling and Pathways Market Share by Players (2018-2023)
Table 21. Global Top Cancer & Tumor Profiling and Pathways Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer & Tumor Profiling and Pathways as of 2022)
Table 22. Ranking of Global Top Cancer & Tumor Profiling and Pathways Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Cancer & Tumor Profiling and Pathways Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cancer & Tumor Profiling and Pathways Product Solution and Service
Table 26. Date of Enter into Cancer & Tumor Profiling and Pathways Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer & Tumor Profiling and Pathways Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Cancer & Tumor Profiling and Pathways Revenue Market Share by Type (2018-2023)
Table 30. Global Cancer & Tumor Profiling and Pathways Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Cancer & Tumor Profiling and Pathways Revenue Market Share by Type (2024-2033)
Table 32. Global Cancer & Tumor Profiling and Pathways Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Cancer & Tumor Profiling and Pathways Revenue Market Share by Application (2018-2023)
Table 34. Global Cancer & Tumor Profiling and Pathways Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Cancer & Tumor Profiling and Pathways Revenue Market Share by Application (2024-2033)
Table 36. North America Cancer & Tumor Profiling and Pathways Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Cancer & Tumor Profiling and Pathways Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Cancer & Tumor Profiling and Pathways Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Cancer & Tumor Profiling and Pathways Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe Cancer & Tumor Profiling and Pathways Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Cancer & Tumor Profiling and Pathways Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific Cancer & Tumor Profiling and Pathways Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific Cancer & Tumor Profiling and Pathways Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Cancer & Tumor Profiling and Pathways Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America Cancer & Tumor Profiling and Pathways Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America Cancer & Tumor Profiling and Pathways Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Cancer & Tumor Profiling and Pathways Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa Cancer & Tumor Profiling and Pathways Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa Cancer & Tumor Profiling and Pathways Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Cancer & Tumor Profiling and Pathways Market Size by Country (2024-2033) & (US$ Million)
Table 51. Illumina, Inc. (US) Company Detail
Table 52. Illumina, Inc. (US) Business Overview
Table 53. Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Product
Table 54. Illumina, Inc. (US) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023) & (US$ Million)
Table 55. Illumina, Inc. (US) Recent Development
Table 56. QIAGEN N.V. (Germany) Company Detail
Table 57. QIAGEN N.V. (Germany) Business Overview
Table 58. QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Product
Table 59. QIAGEN N.V. (Germany) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023) & (US$ Million)
Table 60. QIAGEN N.V. (Germany) Recent Development
Table 61. NeoGenomics Laboratories, Inc. (US) Company Detail
Table 62. NeoGenomics Laboratories, Inc. (US) Business Overview
Table 63. NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Product
Table 64. NeoGenomics Laboratories, Inc. (US) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023) & (US$ Million)
Table 65. NeoGenomics Laboratories, Inc. (US) Recent Development
Table 66. HTG Molecular Diagnostics, Inc. (US) Company Detail
Table 67. HTG Molecular Diagnostics, Inc. (US) Business Overview
Table 68. HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Product
Table 69. HTG Molecular Diagnostics, Inc. (US) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023) & (US$ Million)
Table 70. HTG Molecular Diagnostics, Inc. (US) Recent Development
Table 71. Sysmex Corporation (Japan) Company Detail
Table 72. Sysmex Corporation (Japan) Business Overview
Table 73. Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Product
Table 74. Sysmex Corporation (Japan) Revenue in Cancer & Tumor Profiling and Pathways Business (2018-2023) & (US$ Million)
Table 75. Sysmex Corporation (Japan) Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer & Tumor Profiling and Pathways Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cancer & Tumor Profiling and Pathways Market Share by Type: 2022 VS 2033
Figure 3. Immunoassays Features
Figure 4. Next Generation Sequencing (NGS) Features
Figure 5. Polymerase Chain Reaction (PCR) Features
Figure 6. In-Situ Hybridization (ISH) Features
Figure 7. Microarrays Features
Figure 8. Mass Spectrometry Features
Figure 9. Others Features
Figure 10. Global Cancer & Tumor Profiling and Pathways Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global Cancer & Tumor Profiling and Pathways Market Share by Application: 2022 VS 2033
Figure 12. Research Case Studies
Figure 13. Clinical Case Studies
Figure 14. Cancer & Tumor Profiling and Pathways Report Years Considered
Figure 15. Global Cancer & Tumor Profiling and Pathways Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Cancer & Tumor Profiling and Pathways Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Cancer & Tumor Profiling and Pathways Market Share by Region: 2022 VS 2033
Figure 18. Global Cancer & Tumor Profiling and Pathways Market Share by Players in 2022
Figure 19. Global Top Cancer & Tumor Profiling and Pathways Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer & Tumor Profiling and Pathways as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Cancer & Tumor Profiling and Pathways Revenue in 2022
Figure 21. North America Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Cancer & Tumor Profiling and Pathways Market Share by Country (2018-2033)
Figure 23. United States Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Cancer & Tumor Profiling and Pathways Market Share by Country (2018-2033)
Figure 27. Germany Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Cancer & Tumor Profiling and Pathways Market Share by Region (2018-2033)
Figure 35. China Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Cancer & Tumor Profiling and Pathways Market Share by Country (2018-2033)
Figure 43. Mexico Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Cancer & Tumor Profiling and Pathways Market Share by Country (2018-2033)
Figure 47. Turkey Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Cancer & Tumor Profiling and Pathways Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Illumina, Inc. (US) Revenue Growth Rate in Cancer & Tumor Profiling and Pathways Business (2018-2023)
Figure 50. QIAGEN N.V. (Germany) Revenue Growth Rate in Cancer & Tumor Profiling and Pathways Business (2018-2023)
Figure 51. NeoGenomics Laboratories, Inc. (US) Revenue Growth Rate in Cancer & Tumor Profiling and Pathways Business (2018-2023)
Figure 52. HTG Molecular Diagnostics, Inc. (US) Revenue Growth Rate in Cancer & Tumor Profiling and Pathways Business (2018-2023)
Figure 53. Sysmex Corporation (Japan) Revenue Growth Rate in Cancer & Tumor Profiling and Pathways Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed